NCT04132050View on ClinicalTrials.gov

A Clinical Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788

PHASE3CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

December 24, 2019

Primary Completion Date

December 21, 2021

Study Completion Date

September 25, 2023

Conditions
Idiopathic Thrombocytopenic Purpura
Interventions
DRUG

R788

Oral administration

DRUG

Placebo

Oral administration

Trial Locations (1)

Unknown

Research Site, Multiple Locations

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY